LEADER 00935nam0-22003131i-450-
001 990002866880403321
010  1$a0-471-93990-0
035   $a000286688
035   $aFED01000286688
035   $a(Aleph)000286688FED01
035   $a000286688
100   $a20000920d1993----km-y0itay50------ba
101  1$aENG
200 1 $aStrategic thinking$eLeadership and the management of change$fEdited by John Hendry and Gerry Johnson with Julia Newton
210   $aChichester$aNew York$aBrisbane$cJohn Wiley$d1993
215   $axix, 350 p.$d24 cm
225 1 $a<<The >>Strategic Management Series
700  1$aStrategic$0374118
702  1$aHendry,$bJohn
702  1$aJohnson,$bGerry
702  1$aNewton,$bJulia
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990002866880403321
952   $a1-6-310-TI$b5589$fECA
959   $aECA
996   $aStrategic thinking$9415399
997   $aUNINA
DB    $aING01

LEADER 01442nam  2200385 a 450 
001 9910701393603321
005 20120103162530.0
035   $a(CKB)5470000002417127
035   $a(OCoLC)770099606
035   $a(EXLCZ)995470000002417127
100   $a20120103d2011      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug shortages$b[electronic resource] $eFDA's ability to respond should be strengthened : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate /$fstatement of Marcia Crosse
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2011]
215   $a1 online resource (8 pages)
225 1 $aTestimony ;$vGAO-12-315T
300   $aTitle from PDF title screen (viewed Dec. 29, 2011).
300   $a"For release ... December 15, 2011."
320   $aIncludes bibliographical references.
517   $aDrug shortages 
606   $aPharmaceutical policy$zUnited States
615  0$aPharmaceutical policy
700   $aCrosse$b Marcia$01380679
712 02$aUnited States.$bCongress.$bSenate.$bCommittee on Health, Education, Labor, and Pensions.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910701393603321
996   $aDrug shortages$93436891
997   $aUNINA